2018 Q3 Form 10-Q Financial Statement
#000156459018027435 Filed on November 06, 2018
Income Statement
| Concept | 2018 Q3 | 2017 Q4 | 2017 Q3 |
|---|---|---|---|
| Revenue | $13.74M | $12.11M | $10.49M |
| YoY Change | 30.94% | ||
| Cost Of Revenue | $3.034M | $2.957M | $2.636M |
| YoY Change | 15.1% | ||
| Gross Profit | $10.70M | $9.151M | $7.855M |
| YoY Change | 36.26% | ||
| Gross Profit Margin | 77.91% | 75.58% | 74.87% |
| Selling, General & Admin | $12.91M | $11.47M | $8.822M |
| YoY Change | 46.34% | ||
| % of Gross Profit | 120.62% | 125.29% | 112.31% |
| Research & Development | $2.125M | $1.919M | $1.843M |
| YoY Change | 15.3% | ||
| % of Gross Profit | 19.85% | 20.97% | 23.46% |
| Depreciation & Amortization | $210.0K | $140.0K | $150.0K |
| YoY Change | 40.0% | ||
| % of Gross Profit | 1.96% | 1.53% | 1.91% |
| Operating Expenses | $15.04M | $13.38M | $10.67M |
| YoY Change | 40.98% | ||
| Operating Profit | -$4.332M | -$4.233M | -$2.810M |
| YoY Change | 54.16% | ||
| Interest Expense | $928.0K | $740.0K | $807.0K |
| YoY Change | 14.99% | ||
| % of Operating Profit | |||
| Other Income/Expense, Net | $299.0K | $49.00K | -$136.0K |
| YoY Change | -319.85% | ||
| Pretax Income | -$4.960M | -$4.920M | -$3.750M |
| YoY Change | 32.27% | ||
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$4.961M | -$4.924M | -$3.753M |
| YoY Change | 32.19% | ||
| Net Earnings / Revenue | -36.11% | -40.67% | -35.77% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$282.1K | -$302.8K | -$230.8K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 17.58M | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2018 Q3 | 2017 Q4 | 2017 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $106.8M | ||
| YoY Change | |||
| Cash & Equivalents | $106.8M | $29.15M | $24.15M |
| Short-Term Investments | |||
| Other Short-Term Assets | $2.100M | ||
| YoY Change | |||
| Inventory | $2.600M | $2.468M | |
| Prepaid Expenses | |||
| Receivables | $5.300M | $4.267M | |
| Other Receivables | $0.00 | ||
| Total Short-Term Assets | $116.7M | $37.01M | |
| YoY Change | |||
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $1.343M | $1.359M | |
| YoY Change | |||
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $897.0K | $574.0K | |
| YoY Change | |||
| Total Long-Term Assets | $2.240M | $1.933M | |
| YoY Change | |||
| TOTAL ASSETS | |||
| Total Short-Term Assets | $116.7M | $37.01M | |
| Total Long-Term Assets | $2.240M | $1.933M | |
| Total Assets | $119.0M | $38.94M | |
| YoY Change | |||
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $2.102M | $2.513M | |
| YoY Change | |||
| Accrued Expenses | $6.383M | $7.511M | |
| YoY Change | |||
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | ||
| YoY Change | |||
| Long-Term Debt Due | $5.000M | $0.00 | |
| YoY Change | |||
| Total Short-Term Liabilities | $15.30M | $11.99M | |
| YoY Change | |||
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $25.20M | $29.56M | |
| YoY Change | |||
| Other Long-Term Liabilities | $2.100M | ||
| YoY Change | |||
| Total Long-Term Liabilities | $25.20M | $29.56M | |
| YoY Change | |||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $15.30M | $11.99M | |
| Total Long-Term Liabilities | $25.20M | $29.56M | |
| Total Liabilities | $42.63M | $44.45M | |
| YoY Change | |||
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$196.9M | ||
| YoY Change | |||
| Common Stock | $4.294M | ||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $76.35M | -$192.7M | |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $119.0M | $38.94M | |
| YoY Change |
Cashflow Statement
| Concept | 2018 Q3 | 2017 Q4 | 2017 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$4.961M | -$4.924M | -$3.753M |
| YoY Change | 32.19% | ||
| Depreciation, Depletion And Amortization | $210.0K | $140.0K | $150.0K |
| YoY Change | 40.0% | ||
| Cash From Operating Activities | -$4.920M | $270.0K | -$1.930M |
| YoY Change | 154.92% | ||
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$140.0K | -$270.0K | -$170.0K |
| YoY Change | -17.65% | ||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | -$140.0K | -$270.0K | -$170.0K |
| YoY Change | -17.65% | ||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 97.27M | 5.010M | 10.00K |
| YoY Change | 972600.0% | ||
| NET CHANGE | |||
| Cash From Operating Activities | -4.920M | 270.0K | -1.930M |
| Cash From Investing Activities | -140.0K | -270.0K | -170.0K |
| Cash From Financing Activities | 97.27M | 5.010M | 10.00K |
| Net Change In Cash | 92.21M | 5.010M | -2.090M |
| YoY Change | -4511.96% | ||
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$4.920M | $270.0K | -$1.930M |
| Capital Expenditures | -$140.0K | -$270.0K | -$170.0K |
| Free Cash Flow | -$4.780M | $540.0K | -$1.760M |
| YoY Change | 171.59% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2018Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2082000 | |
| CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1123000 | |
| CY2018Q3 | us-gaap |
Assets Current
AssetsCurrent
|
116739000 | |
| CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
37005000 | |
| CY2018Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1343000 | |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1359000 | |
| CY2018Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
897000 | |
| CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
574000 | |
| CY2018Q3 | us-gaap |
Assets
Assets
|
118979000 | |
| CY2017Q4 | us-gaap |
Assets
Assets
|
38938000 | |
| CY2018Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2102000 | |
| CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2513000 | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9375000 | ||
| CY2018Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
6383000 | |
| CY2017Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
7511000 | |
| CY2018Q3 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
1813000 | |
| CY2017Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
1970000 | |
| CY2018Q3 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
5000000 | |
| CY2018Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
15298000 | |
| CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11994000 | |
| CY2018Q3 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
25198000 | |
| CY2017Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
29556000 | |
| CY2018Q3 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
2032000 | |
| CY2017Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
2275000 | |
| CY2017Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
151000 | |
| CY2017Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
478000 | |
| CY2018Q3 | us-gaap |
Liabilities
Liabilities
|
42631000 | |
| CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
44454000 | |
| CY2018Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2017Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
187136000 | |
| CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2000 | |
| CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
4292000 | |
| CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-196946000 | |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-192652000 | |
| CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
38938000 | |
| CY2017Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.01 | |
| CY2017Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
308593000 | |
| CY2017Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
304958000 | |
| CY2017Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
304958000 | |
| CY2018Q3 | us-gaap |
Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
|
0 | |
| CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
231000 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
231000 | |
| us-gaap |
Revenues
Revenues
|
28325000 | ||
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5735000 | ||
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6018000 | ||
| us-gaap |
Operating Expenses
OperatingExpenses
|
31025000 | ||
| us-gaap |
Interest Expense
InterestExpense
|
2068000 | ||
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
308000 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-11135000 | ||
| CY2018Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
31000 | |
| CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
144000 | |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5497000 | |
| CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-197974000 | |
| CY2018Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
7000 | |
| CY2018Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
192000 | |
| CY2018Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7496000 | |
| CY2018Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-205271000 | |
| CY2018Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
187136000 | |
| CY2018Q3 | stim |
Adjustments To Additional Paid In Capital Conversion Of Convertible Preferred Stock Warrants Into Common Stock Warrants
AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantsIntoCommonStockWarrants
|
1874000 | |
| CY2018Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
96535000 | |
| CY2018Q3 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
7000 | |
| CY2018Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1028000 | |
| CY2018Q3 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
3465000 | |
| us-gaap |
Profit Loss
ProfitLoss
|
-17954000 | ||
| us-gaap |
Profit Loss
ProfitLoss
|
-11135000 | ||
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
671000 | ||
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
455000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
295000 | ||
| stim |
Cost Of Rental Units Purchased By Customers
CostOfRentalUnitsPurchasedByCustomers
|
148000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1016000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
326000 | ||
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
767000 | ||
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
519000 | ||
| us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
298000 | ||
| us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
30000 | ||
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-594000 | ||
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-819000 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-1461000 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
331000 | ||
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-400000 | ||
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-45000 | ||
| us-gaap |
Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
|
46000 | ||
| us-gaap |
Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
|
29000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-18315000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-11412000 | ||
| us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
650000 | ||
| us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
319000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-650000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-319000 | ||
| us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
99998000 | ||
| us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
3465000 | ||
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
45000 | ||
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
30000 | ||
| us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
14825000 | ||
| us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
5000000 | ||
| us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
1015000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
96578000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
18840000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
77613000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
7109000 | ||
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
29147000 | |
| CY2016Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
17040000 | |
| CY2018Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
106760000 | |
| CY2017Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
24149000 | |
| us-gaap |
Interest Paid Net
InterestPaidNet
|
2057000 | ||
| us-gaap |
Interest Paid Net
InterestPaidNet
|
1492000 | ||
| stim |
Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
|
235000 | ||
| stim |
Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
|
248000 | ||
| us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
171000 | ||
| us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
187136000 | ||
| stim |
Conversion Of Convertible Preferred Stock Warrants Into Common Stock Warrant
ConversionOfConvertiblePreferredStockWarrantsIntoCommonStockWarrant
|
1874000 | ||
| us-gaap |
Nature Of Operations
NatureOfOperations
|
<div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.4%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:9pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:9pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:normal;"></font>DESCRIPTION OF BUSINESS </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Neuronetics, Inc., or the Company, is a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. The Company’s first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system was cleared in 2008 by the United States Food and Drug Administration, or the FDA, to treat adult patients with major depressive disorder, or MDD, who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. </p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Initial Public Offering </p> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 2, 2018, the Company closed its initial public offering, or IPO, in which the Company issued and sold 6.325 million shares of its common stock, which included shares sold pursuant to an option granted to the underwriters to purchase additional shares at a public offering price of $17.00 per share. The Company received net proceeds of $96.5 million after deducting underwriting discounts, commissions and other offering expenses paid by the Company. The Company’s common stock is listed on the Nasdaq Global Market under the trading symbol “STIM.” In addition, immediately prior to the closing of the IPO on July 2, 2018, (i) all of the Company’s outstanding shares of convertible preferred stock converted into an aggregate 11.0 million shares of common stock; (ii) all of the Company’s outstanding warrants to purchase convertible preferred stock converted into warrants to purchase common stock; and (iii) the Company filed an amended and restated certificate of incorporation to, among other things, decrease the number of shares of common stock, $0.01 par value per share, authorized for issuance to 200.0 million and to authorize the board of directors to issue up to 10.0 million shares of “blank check” preferred stock, $0.01 par value per share.</p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liquidity</p> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of September 30, 2018, the Company had cash and cash equivalents of $106.8 million and an accumulated deficit of $214.9 million. The Company incurred negative cash flows from operating activities of $11.1 million for the year ended December 31, 2017 and $18.3 million for the nine months ended September 30, 2018. The Company has incurred operating losses since its inception, and management anticipates that its operating losses will continue in the near term as the Company seeks to expand its sales and marketing initiatives to support its growth into existing and new markets and invest in additional research and development activities. The Company’s primary sources of capital to date have been proceeds from its IPO, private placements of its convertible preferred securities, borrowings under its credit facilities and revenues from sales of its products. As of September 30, 2018, the Company had $30.0 million of borrowings outstanding under its credit facility, which matures in March 2022. Management believes that the Company’s cash and cash equivalents as of September 30, 2018 and anticipated revenues from sales of its products are sufficient to fund the Company’s operations for at least the next 24 months after September 30, 2018. </p></div> | ||
| us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.4%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:9pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:9pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:normal;"></font>BASIS OF PRESENTATION </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles, or GAAP. Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification, or ASC, and Accounting Standards Updates, or ASUs, promulgated by the Financial Accounting Standards Board, or FASB. </p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Interim Financial Statements </p> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited interim financial statements have been prepared from the books and records of the Company in accordance with GAAP for interim financial information and Rule 10-01 of Regulation S-X promulgated by the United States Securities and Exchange Commission, or SEC, which permit reduced disclosures for interim periods. All adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the accompanying balance sheets and statements of operations, changes in convertible preferred stock and stockholders’ deficit and cash flows have been made. Although these interim financial statements do not include all of the information and footnotes required for complete annual financial statements, management believes the disclosures are adequate to make the information presented not misleading. Unaudited interim results of operations and cash flows for the three and nine months ended September 30, 2018 are not necessarily indicative of the results that may be expected for the full year. Unaudited interim financial statements and footnotes should be read in conjunction with the audited financial statements and footnotes included in the Company’s IPO prospectus filed with the SEC on June 29, 2018, wherein a more complete discussion of significant accounting policies and certain other information can be found. </p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in accordance with GAAP and the rules and regulations of the SEC requires the use of estimates and assumptions, based on judgments considered reasonable, which affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Although management believes its estimates and assumptions are reasonable when made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Due to the risks and uncertainties involved in the Company’s business and evolving market conditions, and given the subjective element of the estimates and assumptions made, actual results may differ from estimated results. The most significant estimates and judgments impact share-based compensation, product warranty accruals and the net realizable value of inventory. </p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recapitalization</p> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company effected a 0.0345-for-1 reverse split of its common stock on June 14, 2018. The reverse split combined each approximately 29 shares of the Company’s issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion price of its outstanding convertible preferred stock. No fractional shares were issued in connection with the reverse split. Any fractional share resulting from the reverse split was rounded down to the nearest whole share, and in lieu of any fractional share, the Company paid in cash to the holders of such fractional shares an amount equal to the fair market value, as determined by the board of directors, of such fractional shares. All share, per share and related information presented in these interim financial statements and the related notes thereto have been retroactively adjusted, where applicable, to reflect the reverse stock split. </p></div> | ||
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in accordance with GAAP and the rules and regulations of the SEC requires the use of estimates and assumptions, based on judgments considered reasonable, which affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Although management believes its estimates and assumptions are reasonable when made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Due to the risks and uncertainties involved in the Company’s business and evolving market conditions, and given the subjective element of the estimates and assumptions made, actual results may differ from estimated results. The most significant estimates and judgments impact share-based compensation, product warranty accruals and the net realizable value of inventory. </p></div> | ||
| us-gaap |
Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
|
<div> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recapitalization</p> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company effected a 0.0345-for-1 reverse split of its common stock on June 14, 2018. The reverse split combined each approximately 29 shares of the Company’s issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion price of its outstanding convertible preferred stock. No fractional shares were issued in connection with the reverse split. Any fractional share resulting from the reverse split was rounded down to the nearest whole share, and in lieu of any fractional share, the Company paid in cash to the holders of such fractional shares an amount equal to the fair market value, as determined by the board of directors, of such fractional shares. All share, per share and related information presented in these interim financial statements and the related notes thereto have been retroactively adjusted, where applicable, to reflect the reverse stock split. </p></div> | ||
| CY2018Q3 | stim |
Initial Public Offering Closing Date
InitialPublicOfferingClosingDate
|
2018-07-02 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-11100000 | |
| us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
0.0345-for-1 reverse split | ||
| CY2018Q2 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.0345 | |
| CY2018Q3 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1300000 | |
| stim |
Operating Leases Expiration Year
OperatingLeasesExpirationYear
|
2021 | ||
| CY2017Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
478000 | |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
1396000 | ||
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Instruments Classified In Shareholders Equity Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersOutOfLevel3
|
1874000 | ||
| CY2018Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
0 | |
| CY2018Q3 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
5742000 | |
| CY2017Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
4684000 | |
| CY2018Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
459000 | |
| CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
417000 | |
| CY2018Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3318000 | |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3190000 | |
| CY2018Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1975000 | |
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1831000 | |
| CY2018Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
200000 | |
| CY2017Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
100000 | |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
700000 | ||
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
500000 | ||
| CY2018Q3 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
3402000 | |
| CY2017Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
4465000 | |
| CY2018Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
833000 | |
| CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
461000 | |
| CY2018Q3 | stim |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
209000 | |
| CY2017Q4 | stim |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
497000 | |
| CY2018Q3 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
148000 | |
| CY2017Q4 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
620000 | |
| CY2018Q3 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
650000 | |
| CY2017Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
570000 | |
| CY2018Q3 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
376000 | |
| CY2017Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
322000 | |
| CY2018Q3 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
237000 | |
| CY2017Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
188000 | |
| CY2018Q3 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
528000 | |
| CY2017Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
388000 | |
| CY2018Q3 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
30000000 | |
| CY2017Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
30000000 | |
| CY2018Q3 | stim |
Accrued Of Final Payment Fee
AccruedOfFinalPaymentFee
|
1377000 | |
| CY2017Q4 | stim |
Accrued Of Final Payment Fee
AccruedOfFinalPaymentFee
|
940000 | |
| CY2018Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
1179000 | |
| CY2017Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
1384000 | |
| CY2018Q3 | us-gaap |
Long Term Debt
LongTermDebt
|
30198000 | |
| CY2017Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
29556000 | |
| CY2017Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
0 | |
| CY2018Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
700000 | |
| CY2017Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
500000 | |
| CY2018Q3 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
200000 | |
| CY2017Q3 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
300000 | |
| us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
2100000 | ||
| us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
1600000 | ||
| us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
600000 | ||
| us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
500000 | ||
| CY2017Q1 | stim |
Debt Instrument Final Payment Fee
DebtInstrumentFinalPaymentFee
|
1000000 | |
| CY2018Q3 | stim |
Common Stock Shares Issued And Reserved For Future Issuance
CommonStockSharesIssuedAndReservedForFutureIssuance
|
22162000 | |
| CY2017Q4 | stim |
Common Stock Shares Issued And Reserved For Future Issuance
CommonStockSharesIssuedAndReservedForFutureIssuance
|
14040000 | |
| CY2018Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
105000 | |
| CY2018Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1028000 | |
| CY2017Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
97000 | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1364000 | ||
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
295000 | ||
| CY2018Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
2900000 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
4.38 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
100000 | ||
| stim |
Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Weighted Average Grant Date Fair Value Of Underlying Common Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodWeightedAverageGrantDateFairValueOfUnderlyingCommonStock
|
7.19 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
7.19 | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.027 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
|
0.656 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | ||
| CY2018Q2 | stim |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period To Purchase Shares Of Common Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodToPurchaseSharesOfCommonStock
|
54794 | |
| CY2018Q2 | stim |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePrice
|
5.22 | |
| CY2018Q2 | stim |
Share Based Compensation Arrangement By Share Based Payment Award Stock Vesting Period Number Of Monthly Installment
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockVestingPeriodNumberOfMonthlyInstallment
|
12 | |
| CY2018Q2 | stim |
Share Based Compensation Arrangement By Share Based Payment Award Options Estimated Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEstimatedGrantDateFairValue
|
200000 | |
| us-gaap |
Defined Contribution Plan Plan Name
DefinedContributionPlanPlanName
|
401(k) plan | ||
| CY2013Q1 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P93M | |
| us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 |
